Table 2.

Perioperative details

	Initial treatment (n = 387)	Recurrent disease (n = 50)	p value
HIPEC agent (n, %)
Mitomycin C	365 (94%)	10 (20%)	< 0.001
Cisplatin	3 (1%)	23 (46%)
Oxaliplatin	16 (4%)	17 (34%)
Other	3 (1%)	0 (0%)
Completeness of cytoreduction (n, %)
0	252 (65%)	28 (56%)	0.63
1	100 (26%)	19 (38%)
2	24 (6%)	2 (4%)
3	11 (3%)	1 (2%)
Operative time (min) (median, IQR)	511 (418–643)	629 (475–746)	0.002
Length of stay (days) (median, IQR)	13 (10–19)	10 (8–12)	< 0.001
30-Day complications (all grades) (n, %)	282 (73%)	33 (66%)	0.32
90-Day mortality (n, %)	2 (0.5%)	0 (0%)	1.00

Bold indicates statistically significant finding